Characterisation of primitive stem cell-like canine cancer cells: identification of therapeutic targets through genomics

原始干细胞样犬癌细胞的表征：通过基因组学鉴定治疗靶点

• 批准号: BB/F008007/1
• 负责人: Christopher Whitelaw
• 金额: $ 0.89万
• 依托单位: University of Edinburgh
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2008
• 资助国家: 英国
• 起止时间: 2008 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=BB%2FF008007%2F1
• 关键词: Characterisation; primitive; stem; cell; like

Cancer has emerged as a major cause of morbidity and mortality in the dog, with an estimated incidence of 1 in 4. Despite advances in conventional chemotherapy and radiation, complete cures for most cancer types remains elusive, the challenge being to develop highly targeted therapies that kill cancer cells but leave normal cells healthy. For decades the scientific community has accepted a model that most cells in the body have the capacity to undergo genetic changes that ultimately result in them becoming cancerous. However, there has been a recent challenge to this model that suggests that the ability to become a cancer cell is restricted to specific tissue stem cells. These cells give rise to cancer stem cells that drive the production of daughter tumour cells. Daughter cells have the potential to be killed by conventional chemotherapy and radiation in contrast to cells with stem cell capabilities, which are largely resistant to such therapies. The implications of this are immense as it suggests that current therapeutic strategies are not targeting the root of the cancer, the cancer stem cell. There is a growing body of evidence that cancer is a true stem cell disease. Researchers in human medicine have identified putative cancer stem cells from a diverse range of cancers such as breast, colon, pancreas and brain. We have recently applied similar methodologies to the dog and identified a sub-set of cells in bone cancer that have stem cell characteristics. This proposal aims to further characterize these cells and will seek to identify novel signalling pathways in these cells that have the potential to be a therapeutic target. This study will inform the veterinary oncology community of potentially new ways to kill cancer cells. Further, it has the potential to inform similar studies in people and help to further advance the field of stem cell biology.

癌症已成为犬发病和死亡的主要原因，估计发病率为1/4。尽管常规化疗和放疗取得了进展，但大多数癌症类型的完全治愈仍然难以实现，挑战在于开发高度靶向的治疗方法，杀死癌细胞，但使正常细胞保持健康。几十年来，科学界已经接受了一个模型，即人体中的大多数细胞都有能力经历基因变化，最终导致它们癌变。然而，最近对这种模型的挑战表明，成为癌细胞的能力仅限于特定的组织干细胞。这些细胞产生癌症干细胞，驱动子肿瘤细胞的产生。与具有干细胞能力的细胞相比，子细胞有可能被常规化疗和放疗杀死，而干细胞能力在很大程度上对这些疗法有抵抗力。这一点的意义是巨大的，因为它表明目前的治疗策略并没有针对癌症的根源，即癌症干细胞。越来越多的证据表明癌症是一种真正的干细胞疾病。人类医学的研究人员已经从多种癌症中鉴定出了假定的癌症干细胞，如乳腺癌、结肠癌、胰腺癌和脑癌。我们最近将类似的方法应用于狗，并确定了骨癌中具有干细胞特征的细胞子集。该提案旨在进一步表征这些细胞，并将寻求确定这些细胞中有可能成为治疗靶点的新信号通路。这项研究将为兽医肿瘤学界提供潜在的杀死癌细胞的新方法。此外，它有可能为人类的类似研究提供信息，并有助于进一步推进干细胞生物学领域。